Statin treatment for primary and secondary prevention in elderly patients-a cross-sectional study in Stockholm, Sweden

被引:1
作者
Wettermark, Bjorn [1 ]
Kalantaripour, Camelia [1 ]
Forslund, Tomas [2 ]
Hjemdahl, Paul [3 ,4 ]
机构
[1] Uppsala Univ, Fac Pharm, Dept Pharm, Box 580, S-75123 Uppsala, Sweden
[2] Acad Primary Hlth Care Ctr, Stockholm, Stockholm Regio, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden
[4] Karolinska Univ Hosp, Clin Pharmacol, Stockholm, Sweden
关键词
Drug utilization; Statins; Elderly; Hyperlipidemia; Cardiovascular prevention; VASCULAR-DISEASE; ALL-CAUSE; OLDER; THERAPY; METAANALYSIS; ASSOCIATION; INDIVIDUALS; CHOLESTEROL; MORTALITY; PATTERNS;
D O I
10.1007/s00228-024-03724-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundAge is a major risk factor for atherosclerotic cardiovascular disease (CVD) and death, but there has been a debate about benefit-risk of statin treatment in the elderly with limited evidence on benefits for primary prevention, while there is strong evidence for its use in secondary prevention.AimThe aim of this study was to provide an overview of statin utilization in primary and secondary prevention for patients 75-84 years and >= 85 years in the Swedish capital Region Stockholm in 2019.MethodsThis is a cross-sectional study based on the regional healthcare database VAL containing all diagnoses and dispensed prescription drugs for all 174,950 inhabitants >= 75 years old in the Stockholm Region. Prevalence and incidence were analyzed by sex, age, cardiovascular risk, substance, and the intensity of treatment.ResultsA total of 35% of all individuals above the age of 75 in the region were treated with statins in 2019. The overall incidence in this age group was 31 patients per 1000 inhabitants. Men, individuals 75-84 compared to >= 85 years of age, and those with higher cardiovascular risk were treated to a greater extent. Simvastatin was used primarily by prevalent users and atorvastatin by incident users. The majority was treated with moderate-intensity dosages and fewer women received high intensity treatment.ConclusionsStatins are widely prescribed in the elderly. Physicians seem to consider individual cardiovascular risk when deciding to initiate statin treatment for elderly patients, but here may still be some undertreatment among high-risk patients (especially women and elderly 85 + years) and some overtreatment among patients with low-risk for CVD.
引用
收藏
页码:1571 / 1580
页数:10
相关论文
共 59 条
[1]   Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects [J].
Ahmed, Sarah T. ;
Akeroyd, Julia M. ;
Mahtta, Dhruv ;
Street, Richard ;
Slagle, Jason ;
Navar, Ann Marie ;
Stone, Neil J. ;
Ballantyne, Christie M. ;
Petersen, Laura A. ;
Virani, Salim S. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (22)
[2]   A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke [J].
Amarenco, P. ;
Kim, J. S. ;
Labreuche, J. ;
Charles, H. ;
Abtan, J. ;
Bejot, Y. ;
Cabrejo, L. ;
Cha, J-K ;
Ducrocq, G. ;
Giroud, M. ;
Guidoux, C. ;
Hobeanu, C. ;
Kim, Y. J. ;
Lapergue, B. ;
Lavallee, P. C. ;
Lee, B-C ;
Lee, K-B ;
Leys, D. ;
Mahagne, M-H ;
Meseguer, E. ;
Nighoghossian, N. ;
Pico, F. ;
Samson, Y. ;
Sibon, I ;
Steg, P. G. ;
Sung, S-M ;
Touboul, P. J. ;
Touze, E. ;
Varenne, O. ;
Vicaut, E. ;
Yelles, N. ;
Bruckert, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :9-19
[3]  
[Anonymous], WHO COLLABORATING CT
[4]   Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study [J].
Bezin, Julien ;
Moore, Nicholas ;
Mansiaux, Yohann ;
Steg, Philippe Gabriel ;
Pariente, Antoine .
AMERICAN JOURNAL OF MEDICINE, 2019, 132 (06) :740-+
[5]  
Brown F, 2017, CAN FAM PHYSICIAN, V63, pE495
[6]   Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study [J].
Bruckert, E ;
Hayem, G ;
Dejager, S ;
Yau, C ;
Bégaud, B .
CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (06) :403-414
[7]   High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health [J].
Carlsson, Axel C. ;
Wandell, Per ;
Osby, Urban ;
Zarrinkoub, Ramin ;
Wettermark, Bjorn ;
Ljunggren, Gunnar .
BMC PUBLIC HEALTH, 2013, 13
[8]  
Collins R, 2012, LANCET, V379, P1173, DOI [10.1016/S0140-6736(16)31357-5, 10.1016/S0140-6736(12)60404-8]
[9]   Adverse drug reactions in special populations - the elderly [J].
Davies, E. A. ;
O'Mahony, M. S. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) :796-807
[10]   Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women [J].
Driscoll, A. ;
Beauchamp, A. ;
Lyubomirsky, G. ;
Demos, L. ;
McNeil, J. ;
Tonkin, A. .
INTERNAL MEDICINE JOURNAL, 2011, 41 (10) :730-736